 | • レポートコード：QFJ1-4006 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、舞踏病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、外科療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・舞踏病治療の市場動向 ・企業の競争状況、市場シェア ・舞踏病治療の種類別市場規模と予測2016-2027（医薬品、外科療法） ・舞踏病治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・舞踏病治療の北米市場規模2016-2027（アメリカ、カナダ） ・舞踏病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・舞踏病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・舞踏病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・舞踏病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medtronic、Boston Scientific、Aleva Neurotherapeutics、Teva Pharmaceutical、Pfizer、GlaxoSmithKline、Bausch Health Companies、LivaNova、Lundbeck、Ipsen、Alnylam Pharmaceuticals、Prana Biotechnology、RespireRx Pharmaceuticals、Vertex Pharmaceuticals、SOM Biotech） ・結論 |
Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.
Market Analysis and Insights: Global Chorea Treatment Market
The global Chorea Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chorea Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chorea Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chorea Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chorea Treatment market.
Global Chorea Treatment Scope and Market Size
Chorea Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chorea Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medication
Surgery Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Medtronic
Boston Scientific
Aleva Neurotherapeutics
Teva Pharmaceutical
Pfizer
GlaxoSmithKline
Bausch Health Companies
LivaNova
Lundbeck
Ipsen
Alnylam Pharmaceuticals
Prana Biotechnology
RespireRx Pharmaceuticals
Vertex Pharmaceuticals
SOM Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chorea Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Surgery Therapy
1.3 Market by Application
1.3.1 Global Chorea Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chorea Treatment Market Perspective (2016-2027)
2.2 Chorea Treatment Growth Trends by Regions
2.2.1 Chorea Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chorea Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chorea Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chorea Treatment Industry Dynamic
2.3.1 Chorea Treatment Market Trends
2.3.2 Chorea Treatment Market Drivers
2.3.3 Chorea Treatment Market Challenges
2.3.4 Chorea Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chorea Treatment Players by Revenue
3.1.1 Global Top Chorea Treatment Players by Revenue (2016-2021)
3.1.2 Global Chorea Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chorea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chorea Treatment Revenue
3.4 Global Chorea Treatment Market Concentration Ratio
3.4.1 Global Chorea Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chorea Treatment Revenue in 2020
3.5 Chorea Treatment Key Players Head office and Area Served
3.6 Key Players Chorea Treatment Product Solution and Service
3.7 Date of Enter into Chorea Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chorea Treatment Breakdown Data by Type
4.1 Global Chorea Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chorea Treatment Forecasted Market Size by Type (2022-2027)
5 Chorea Treatment Breakdown Data by Application
5.1 Global Chorea Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chorea Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chorea Treatment Market Size (2016-2027)
6.2 North America Chorea Treatment Market Size by Type
6.2.1 North America Chorea Treatment Market Size by Type (2016-2021)
6.2.2 North America Chorea Treatment Market Size by Type (2022-2027)
6.2.3 North America Chorea Treatment Market Size by Type (2016-2027)
6.3 North America Chorea Treatment Market Size by Application
6.3.1 North America Chorea Treatment Market Size by Application (2016-2021)
6.3.2 North America Chorea Treatment Market Size by Application (2022-2027)
6.3.3 North America Chorea Treatment Market Size by Application (2016-2027)
6.4 North America Chorea Treatment Market Size by Country
6.4.1 North America Chorea Treatment Market Size by Country (2016-2021)
6.4.2 North America Chorea Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Chorea Treatment Market Size (2016-2027)
7.2 Europe Chorea Treatment Market Size by Type
7.2.1 Europe Chorea Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chorea Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chorea Treatment Market Size by Type (2016-2027)
7.3 Europe Chorea Treatment Market Size by Application
7.3.1 Europe Chorea Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chorea Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chorea Treatment Market Size by Application (2016-2027)
7.4 Europe Chorea Treatment Market Size by Country
7.4.1 Europe Chorea Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chorea Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chorea Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chorea Treatment Market Size by Type
8.2.1 Asia-Pacific Chorea Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chorea Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chorea Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chorea Treatment Market Size by Application
8.3.1 Asia-Pacific Chorea Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chorea Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chorea Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chorea Treatment Market Size by Region
8.4.1 Asia-Pacific Chorea Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chorea Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chorea Treatment Market Size (2016-2027)
9.2 Latin America Chorea Treatment Market Size by Type
9.2.1 Latin America Chorea Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chorea Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chorea Treatment Market Size by Type (2016-2027)
9.3 Latin America Chorea Treatment Market Size by Application
9.3.1 Latin America Chorea Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chorea Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chorea Treatment Market Size by Application (2016-2027)
9.4 Latin America Chorea Treatment Market Size by Country
9.4.1 Latin America Chorea Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chorea Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chorea Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chorea Treatment Market Size by Type
10.2.1 Middle East & Africa Chorea Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chorea Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chorea Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chorea Treatment Market Size by Application
10.3.1 Middle East & Africa Chorea Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chorea Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chorea Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chorea Treatment Market Size by Country
10.4.1 Middle East & Africa Chorea Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chorea Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Chorea Treatment Introduction
11.1.4 Medtronic Revenue in Chorea Treatment Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Chorea Treatment Introduction
11.2.4 Boston Scientific Revenue in Chorea Treatment Business (2016-2021)
11.2.5 Boston Scientific Recent Development
11.3 Aleva Neurotherapeutics
11.3.1 Aleva Neurotherapeutics Company Details
11.3.2 Aleva Neurotherapeutics Business Overview
11.3.3 Aleva Neurotherapeutics Chorea Treatment Introduction
11.3.4 Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2016-2021)
11.3.5 Aleva Neurotherapeutics Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Chorea Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Chorea Treatment Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Chorea Treatment Introduction
11.5.4 Pfizer Revenue in Chorea Treatment Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chorea Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Chorea Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Details
11.7.2 Bausch Health Companies Business Overview
11.7.3 Bausch Health Companies Chorea Treatment Introduction
11.7.4 Bausch Health Companies Revenue in Chorea Treatment Business (2016-2021)
11.7.5 Bausch Health Companies Recent Development
11.8 LivaNova
11.8.1 LivaNova Company Details
11.8.2 LivaNova Business Overview
11.8.3 LivaNova Chorea Treatment Introduction
11.8.4 LivaNova Revenue in Chorea Treatment Business (2016-2021)
11.8.5 LivaNova Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Chorea Treatment Introduction
11.9.4 Lundbeck Revenue in Chorea Treatment Business (2016-2021)
11.9.5 Lundbeck Recent Development
11.10 Ipsen
11.10.1 Ipsen Company Details
11.10.2 Ipsen Business Overview
11.10.3 Ipsen Chorea Treatment Introduction
11.10.4 Ipsen Revenue in Chorea Treatment Business (2016-2021)
11.10.5 Ipsen Recent Development
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Details
11.11.2 Alnylam Pharmaceuticals Business Overview
11.11.3 Alnylam Pharmaceuticals Chorea Treatment Introduction
11.11.4 Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2016-2021)
11.11.5 Alnylam Pharmaceuticals Recent Development
11.12 Prana Biotechnology
11.12.1 Prana Biotechnology Company Details
11.12.2 Prana Biotechnology Business Overview
11.12.3 Prana Biotechnology Chorea Treatment Introduction
11.12.4 Prana Biotechnology Revenue in Chorea Treatment Business (2016-2021)
11.12.5 Prana Biotechnology Recent Development
11.13 RespireRx Pharmaceuticals
11.13.1 RespireRx Pharmaceuticals Company Details
11.13.2 RespireRx Pharmaceuticals Business Overview
11.13.3 RespireRx Pharmaceuticals Chorea Treatment Introduction
11.13.4 RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2016-2021)
11.13.5 RespireRx Pharmaceuticals Recent Development
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Details
11.14.2 Vertex Pharmaceuticals Business Overview
11.14.3 Vertex Pharmaceuticals Chorea Treatment Introduction
11.14.4 Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2016-2021)
11.14.5 Vertex Pharmaceuticals Recent Development
11.15 SOM Biotech
11.15.1 SOM Biotech Company Details
11.15.2 SOM Biotech Business Overview
11.15.3 SOM Biotech Chorea Treatment Introduction
11.15.4 SOM Biotech Revenue in Chorea Treatment Business (2016-2021)
11.15.5 SOM Biotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chorea Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Surgery Therapy
Table 4. Global Chorea Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Chorea Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chorea Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Chorea Treatment Market Share by Regions (2016-2021)
Table 8. Global Chorea Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Chorea Treatment Market Share by Regions (2022-2027)
Table 10. Chorea Treatment Market Trends
Table 11. Chorea Treatment Market Drivers
Table 12. Chorea Treatment Market Challenges
Table 13. Chorea Treatment Market Restraints
Table 14. Global Chorea Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Chorea Treatment Market Share by Players (2016-2021)
Table 16. Global Top Chorea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chorea Treatment as of 2020)
Table 17. Ranking of Global Top Chorea Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Chorea Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chorea Treatment Product Solution and Service
Table 21. Date of Enter into Chorea Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chorea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Chorea Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Chorea Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Chorea Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Chorea Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Chorea Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Chorea Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Chorea Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Chorea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Chorea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Chorea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Chorea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Chorea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Chorea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Chorea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Chorea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Chorea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Chorea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Chorea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Chorea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Chorea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Chorea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chorea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chorea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chorea Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Chorea Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Chorea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Chorea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Chorea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Chorea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Chorea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Chorea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Chorea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Chorea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chorea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chorea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chorea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Chorea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Medtronic Company Details
Table 62. Medtronic Business Overview
Table 63. Medtronic Chorea Treatment Product
Table 64. Medtronic Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 65. Medtronic Recent Development
Table 66. Boston Scientific Company Details
Table 67. Boston Scientific Business Overview
Table 68. Boston Scientific Chorea Treatment Product
Table 69. Boston Scientific Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 70. Boston Scientific Recent Development
Table 71. Aleva Neurotherapeutics Company Details
Table 72. Aleva Neurotherapeutics Business Overview
Table 73. Aleva Neurotherapeutics Chorea Treatment Product
Table 74. Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 75. Aleva Neurotherapeutics Recent Development
Table 76. Teva Pharmaceutical Company Details
Table 77. Teva Pharmaceutical Business Overview
Table 78. Teva Pharmaceutical Chorea Treatment Product
Table 79. Teva Pharmaceutical Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceutical Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Chorea Treatment Product
Table 84. Pfizer Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Chorea Treatment Product
Table 89. GlaxoSmithKline Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Bausch Health Companies Company Details
Table 92. Bausch Health Companies Business Overview
Table 93. Bausch Health Companies Chorea Treatment Product
Table 94. Bausch Health Companies Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 95. Bausch Health Companies Recent Development
Table 96. LivaNova Company Details
Table 97. LivaNova Business Overview
Table 98. LivaNova Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 99. LivaNova Recent Development
Table 100. Lundbeck Company Details
Table 101. Lundbeck Business Overview
Table 102. Lundbeck Chorea Treatment Product
Table 103. Lundbeck Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 104. Lundbeck Recent Development
Table 105. Ipsen Company Details
Table 106. Ipsen Business Overview
Table 107. Ipsen Chorea Treatment Product
Table 108. Ipsen Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 109. Ipsen Recent Development
Table 110. Alnylam Pharmaceuticals Company Details
Table 111. Alnylam Pharmaceuticals Business Overview
Table 112. Alnylam Pharmaceuticals Chorea Treatment Product
Table 113. Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 114. Alnylam Pharmaceuticals Recent Development
Table 115. Prana Biotechnology Company Details
Table 116. Prana Biotechnology Business Overview
Table 117. Prana Biotechnology Chorea Treatment Product
Table 118. Prana Biotechnology Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 119. Prana Biotechnology Recent Development
Table 120. RespireRx Pharmaceuticals Company Details
Table 121. RespireRx Pharmaceuticals Business Overview
Table 122. RespireRx Pharmaceuticals Chorea Treatment Product
Table 123. RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 124. RespireRx Pharmaceuticals Recent Development
Table 125. Vertex Pharmaceuticals Company Details
Table 126. Vertex Pharmaceuticals Business Overview
Table 127. Vertex Pharmaceuticals Chorea Treatment Product
Table 128. Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 129. Vertex Pharmaceuticals Recent Development
Table 130. SOM Biotech Company Details
Table 131. SOM Biotech Business Overview
Table 132. SOM Biotech Chorea Treatment Product
Table 133. SOM Biotech Revenue in Chorea Treatment Business (2016-2021) & (US$ Million)
Table 134. SOM Biotech Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chorea Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Surgery Therapy Features
Figure 4. Global Chorea Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Chorea Treatment Report Years Considered
Figure 9. Global Chorea Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Chorea Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Chorea Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Chorea Treatment Market Share by Regions (2022-2027)
Figure 13. Global Chorea Treatment Market Share by Players in 2020
Figure 14. Global Top Chorea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chorea Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Chorea Treatment Revenue in 2020
Figure 16. Global Chorea Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Chorea Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Chorea Treatment Market Share by Type (2016-2027)
Figure 20. North America Chorea Treatment Market Share by Application (2016-2027)
Figure 21. North America Chorea Treatment Market Share by Country (2016-2027)
Figure 22. United States Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chorea Treatment Market Share by Type (2016-2027)
Figure 26. Europe Chorea Treatment Market Share by Application (2016-2027)
Figure 27. Europe Chorea Treatment Market Share by Country (2016-2027)
Figure 28. Germany Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chorea Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Chorea Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Chorea Treatment Market Share by Region (2016-2027)
Figure 38. China Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chorea Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Chorea Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Chorea Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chorea Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Chorea Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Chorea Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Chorea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Medtronic Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 58. Boston Scientific Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 59. Aleva Neurotherapeutics Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 63. Bausch Health Companies Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 64. LivaNova Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 65. Lundbeck Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 66. Ipsen Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 67. Alnylam Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 68. Prana Biotechnology Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 69. RespireRx Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 70. Vertex Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 71. SOM Biotech Revenue Growth Rate in Chorea Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…- 世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Medication Treatment …
- 世界の足底筋膜炎治療市場規模・現状・予測（2021年-2027年） Plantar fasciitis is a disorder of the connective tissue which supports the arch of the foot. It results in pain in the heel and bottom of the foot that is usually most severe with the first steps of the day or following a period of rest. Pain is also frequently brought on by bending the foot and to…
- 世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…
- 世界の脳性麻痺治療市場規模・現状・予測（2021年-2027年） Cerebral palsy (CP) is a group of permanent movement disorders that appear in early childhood. Signs and symptoms vary among people. Often, symptoms include poor coordination, stiff muscles, weak muscles, and tremors. There may be problems with sensation, vision, hearing, swallowing, and speaking. O…